FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2005199440> ?p ?o ?g. }

• W2005199440 endingPage "8" @default.
• W2005199440 startingPage "1" @default.
• W2005199440 abstract "Introduction . Biological markers as Her2/neu, p53, and hormonal receptors (HmRs) may be reliable parameters for prognostic assessment of patients of locally advanced breast cancer (LABC). This work aims at assessing the potential value of these biological markers for the prediction of disease outcome after neoadjuvant taxane-based chemotherapy and its implication on the surgical role. Patients and Methods . From March 2006 to September 2011, 95 patients with LABC were treated by neoadjuvant taxane-based chemotherapy given at intervals of 3 weeks. Expression of Her2/neu and p53 was examined in the initial tissue biopsy by using ELISA technique. Status of HmRs was determined using a commercial enzyme immunoassay. Three weeks after the third cycle, patients underwent surgical resection followed by 3 more cycles of taxane-based chemotherapy and radiotherapy as an adjuvant therapy. Relations of Her2/neu overexpression to p53, HmRs, and conventional prognostic factors were analyzed. Results . Median followup was 61 months. The 5-year DFS and OAS rates were significantly higher in patients with positive HmRs than in those with negative HmRs, patients with Her2− than those with Her2+ breast cancer, and patients with intact p53 breast cancer than those with inactive p53. HER-2 overexpression was statistically significant associated with loss of HmR positive immunostaining (), grade III breast cancer (), advanced nodal status (), and younger (<50 years) age (). Conclusion . Her2/neu overexpression was associated with poor DFS and OAS rates, as it was significantly associated with negative HmR and high grade." @default.
• W2005199440 created "2016-06-24" @default.
• W2005199440 creator A5013229201 @default.
• W2005199440 creator A5031754158 @default.
• W2005199440 creator A5053257588 @default.
• W2005199440 creator A5066241269 @default.
• W2005199440 date "2012-12-17" @default.
• W2005199440 modified "2023-10-01" @default.
• W2005199440 title "Biological Markers and Response to Neoadjuvant Taxane-Based Chemotherapy in Patients with Locally Advanced Breast Cancer" @default.
• W2005199440 cites W1775749144 @default.
• W2005199440 cites W1816051628 @default.
• W2005199440 cites W1881540319 @default.
• W2005199440 cites W1928289361 @default.
• W2005199440 cites W1971423060 @default.
• W2005199440 cites W1973658923 @default.
• W2005199440 cites W1974026856 @default.
• W2005199440 cites W1977742013 @default.
• W2005199440 cites W1979319210 @default.
• W2005199440 cites W1985961433 @default.
• W2005199440 cites W1990966731 @default.
• W2005199440 cites W2000557631 @default.
• W2005199440 cites W2008111120 @default.
• W2005199440 cites W2013282919 @default.
• W2005199440 cites W2013920437 @default.
• W2005199440 cites W2014907222 @default.
• W2005199440 cites W2020256980 @default.
• W2005199440 cites W2050466428 @default.
• W2005199440 cites W2075181232 @default.
• W2005199440 cites W2090099441 @default.
• W2005199440 cites W2093855653 @default.
• W2005199440 cites W2096281534 @default.
• W2005199440 cites W2106198994 @default.
• W2005199440 cites W2113242459 @default.
• W2005199440 cites W213957447 @default.
• W2005199440 cites W2141393790 @default.
• W2005199440 cites W2151859419 @default.
• W2005199440 cites W2157481658 @default.
• W2005199440 cites W2159610922 @default.
• W2005199440 cites W2162760540 @default.
• W2005199440 cites W2163134191 @default.
• W2005199440 cites W2165038925 @default.
• W2005199440 cites W2165884472 @default.
• W2005199440 cites W2204696794 @default.
• W2005199440 cites W2411814058 @default.
• W2005199440 cites W2789565876 @default.
• W2005199440 cites W35647293 @default.
• W2005199440 cites W4211061808 @default.
• W2005199440 doi "https://doi.org/10.5402/2012/245891" @default.
• W2005199440 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3536061" @default.
• W2005199440 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23316390" @default.
• W2005199440 hasPublicationYear "2012" @default.
• W2005199440 type Work @default.
• W2005199440 sameAs 2005199440 @default.
• W2005199440 citedByCount "2" @default.
• W2005199440 countsByYear W20051994402021 @default.
• W2005199440 countsByYear W20051994402023 @default.
• W2005199440 crossrefType "journal-article" @default.
• W2005199440 hasAuthorship W2005199440A5013229201 @default.
• W2005199440 hasAuthorship W2005199440A5031754158 @default.
• W2005199440 hasAuthorship W2005199440A5053257588 @default.
• W2005199440 hasAuthorship W2005199440A5066241269 @default.
• W2005199440 hasBestOaLocation W20051994401 @default.
• W2005199440 hasConcept C121608353 @default.
• W2005199440 hasConcept C126322002 @default.
• W2005199440 hasConcept C143998085 @default.
• W2005199440 hasConcept C146357865 @default.
• W2005199440 hasConcept C151730666 @default.
• W2005199440 hasConcept C2776694085 @default.
• W2005199440 hasConcept C2777511904 @default.
• W2005199440 hasConcept C2778292576 @default.
• W2005199440 hasConcept C509974204 @default.
• W2005199440 hasConcept C530470458 @default.
• W2005199440 hasConcept C71924100 @default.
• W2005199440 hasConcept C86803240 @default.
• W2005199440 hasConceptScore W2005199440C121608353 @default.
• W2005199440 hasConceptScore W2005199440C126322002 @default.
• W2005199440 hasConceptScore W2005199440C143998085 @default.
• W2005199440 hasConceptScore W2005199440C146357865 @default.
• W2005199440 hasConceptScore W2005199440C151730666 @default.
• W2005199440 hasConceptScore W2005199440C2776694085 @default.
• W2005199440 hasConceptScore W2005199440C2777511904 @default.
• W2005199440 hasConceptScore W2005199440C2778292576 @default.
• W2005199440 hasConceptScore W2005199440C509974204 @default.
• W2005199440 hasConceptScore W2005199440C530470458 @default.
• W2005199440 hasConceptScore W2005199440C71924100 @default.
• W2005199440 hasConceptScore W2005199440C86803240 @default.
• W2005199440 hasLocation W20051994401 @default.
• W2005199440 hasLocation W20051994402 @default.
• W2005199440 hasLocation W20051994403 @default.
• W2005199440 hasLocation W20051994404 @default.
• W2005199440 hasOpenAccess W2005199440 @default.
• W2005199440 hasPrimaryLocation W20051994401 @default.
• W2005199440 hasRelatedWork W1255356622 @default.
• W2005199440 hasRelatedWork W2013223170 @default.
• W2005199440 hasRelatedWork W2020150632 @default.
• W2005199440 hasRelatedWork W2358701816 @default.
• W2005199440 hasRelatedWork W2367105124 @default.
• W2005199440 hasRelatedWork W2388481412 @default.

• next